ECSP951390A - QUINAZOLINE DERIVATIVES - Google Patents

QUINAZOLINE DERIVATIVES

Info

Publication number
ECSP951390A
ECSP951390A ECSP951390A ECSP951390A EC SP951390 A ECSP951390 A EC SP951390A EC SP951390 A ECSP951390 A EC SP951390A EC SP951390 A ECSP951390 A EC SP951390A
Authority
EC
Ecuador
Prior art keywords
quinazoline derivatives
treatment
certain
relates
quinazoline
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Lee Daniel Arnold
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP951390 priority Critical patent/ECSP951390A/en
Publication of ECSP951390A publication Critical patent/ECSP951390A/en

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere a ciertas 4-amino-quinazolinas útiles para el tratamiento de enfermedades hiperproliferativas.This invention relates to certain 4-amino quinazolines useful for the treatment of hyperproliferative diseases.

ECSP951390 1995-02-21 1995-02-21 QUINAZOLINE DERIVATIVES ECSP951390A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP951390 ECSP951390A (en) 1995-02-21 1995-02-21 QUINAZOLINE DERIVATIVES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP951390 ECSP951390A (en) 1995-02-21 1995-02-21 QUINAZOLINE DERIVATIVES

Publications (1)

Publication Number Publication Date
ECSP951390A true ECSP951390A (en) 1996-01-15

Family

ID=42042035

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP951390 ECSP951390A (en) 1995-02-21 1995-02-21 QUINAZOLINE DERIVATIVES

Country Status (1)

Country Link
EC (1) ECSP951390A (en)

Similar Documents

Publication Publication Date Title
CO4340688A1 (en) QUINAZOLINE DERIVATIVES AND PROCEDURES FOR THE USE OF THE SAME, AS AGENTS AGAINST CANCER, IN MAMMALS.
ECSP034797A (en) DIHIDRO-BENZO DERIVATIVES [b] [1,4] DIAZEPIN-2-ONA AS ANTAGONISTS II MGLUR2
DE69536015D1 (en) Quinazolinone derivatives
DK1187632T3 (en) Treatment with anti-ErbB2 antibodies
PA8543201A1 (en) DERIVATIVES OF DIHIDRO-BENZO [B] [1,4] -DIAZEPIN-2-ONA AS ANTAGONISTS I OF mGluR2
PT639577E (en) PHOSPHONUM-OXYMETHYRIC OR METHYLTHYMETHYL ETERS OF TAXANE DERIVATIVES AS ANTI-TUMOR AGENTS
ES2173876T3 (en) NEW 7- (REPLACED) -8- (REPLACED) -9- (AMINO REPLACED) -6-DEMET-DETOXITETHYCLINES AS ANTIBIOTIC AGENTS.
NO20014560L (en) Quinasolines and their therapeutic use
BR0116452A (en) Compound, pharmaceutical composition, use of a compound
DE69930328D1 (en) Dimer pyrrolobenzodiazepines
FI941580A (en) Bicyclic ansamycins
ES2180899T3 (en) OLANZAPINE DIHYDRATE.
HN1997000146A (en) DERIVATIVES OF CONDENSED BICYCLIC PIRIMIDINE
DK0811110T3 (en) Oil Source Treatment
PT1028950E (en) QUINAZOLIN-2,4-DIONAS 7-SUBSTITUTES UTEIS AS ANTIBACTERIAL AGENTS
AR002336A1 (en) Effluent gas treatment process
HUP0101818A1 (en) N-(3-ethynylpheyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate and pharmaceutical compositions containing the same
EE200300559A (en) Use of Osteopontin for the treatment and / or prevention of neurological disorders
ES2162110T3 (en) DERIVATIVES OF ANTIMALARY QUINOLINE.
ES2170176T3 (en) USE OF ANTAGONISTS OF SEROTONINE AND DOPAMINE RECEPTORS FOR THE TREATMENT OF MENTAL DISEASES RESULTING FROM CEREBROVASCULAR DISEASES.
ES2082029T3 (en) DIFLUOROGLUTAMIC ACID CONJUGATES WITH FOLIATES AND ANTIFOLIATES FOR THE TREATMENT OF NEOPLASTIC DISEASES.
ECSP951390A (en) QUINAZOLINE DERIVATIVES
NO990450D0 (en) Treatment of mental disorders
EE03437B1 (en) Benzenamides for the treatment of neurodegenerative diseases
IT1289154B1 (en) ISOFLAVONE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC USE